Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Spritam

    - PMLiVE

    UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome

    The study demonstrated a sustained reduction in seizures for patients

    Epilepsy meds app silver award at PMi Awards

    Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App

    Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

    Genetic Digital

    Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds.

    Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App

    Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...

    Genetic Digital

    - PMLiVE

    UCB shares promising results for fenfluramine in ultra-rare form of epilepsy

    CDKL5 deficiency disorder occurs in approximately one in 40,000 to 60,000 live births

    Genesis Research Group A&P image

    Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

    In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

    Genesis Research Group

    - PMLiVE

    Communicating value to US Payers: Insights for Pharma and Medtech

    What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...

    Petauri Evidence

    - PMLiVE

    Takeda shares late-stage results for investigational soticlestat in rare epileptic disorders

    Dravet syndrome and Lennox-Gastaut syndrome are drug-resistant to many anti-seizure medications

    - PMLiVE

    Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

    Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

    Inizio

    EU flag

    EC approves UCB’s Fintepla to treat severe form of epilepsy

    Lennox-Gastaut syndrome affects around two in 10,000 people in the EU and usually begins in early childhood

    - PMLiVE

    WHO publishes brief calling for integrated approach to epilepsy treatment

    Epilepsy affects over 50 million people globally and accounts for 125,000 death per year

    - PMLiVE

    NHS to roll out brain laser therapy for epilepsy patients

    There are around 600,000 people living with epilepsy across the UK

    - PMLiVE

    US backs proposal to waive IP protection for COVID-19 vaccines

    "Monumental decision" could see IP protections for COVID-19 vaccines temporarily removed

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links